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Abstract
Pathologists are an integral member of the colorectal multidisciplinary team and are able to closely interact with 
surgeons, radiologists and oncologists to facilitate improvements in surgical quality and patient outcomes. Accurate, 
high quality pathology reports containing all vital prognostic information are essential to ensure the patient receives 
optimal treatment. These reports should also integrate feedback to all members of the multidisciplinary team on the 
accuracy of preoperative staging, response to preoperative treatment, and the quality of surgery. Pathologists have 
played a key role in improving outcomes in patients with rectal cancer by recognising the prognostic importance of an 
involved circumferential resection margin. In addition, pathologists have described an assessment of the surgical planes 
of dissection as a marker of surgical quality and thereby a means of quality control. This article will review the current 
best practice for the pathological assessment of anterior resections and abdominoperineal excisions for rectal cancer 
and ultimately look at how pathologists can influence quality control in rectal cancer surgery.
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INTRODUCTION
Pathologists play a key role in the modern multidisciplinary management of patients with rectal cancer. 
Pathological assessment of the resected specimen not only provides key prognostic information, e.g., 
primary staging of the tumour and identification of high risk features, but also allows evaluation of the 
quality of the surgery, accuracy of radiology, and an assessment of response to neoadjuvant therapy. 
Pathologists therefore have a unique opportunity, and responsibility, to provide feedback to all members 
of the multidisciplinary team (MDT), in particular surgeons, radiologists and oncologists, on the quality 
of their services for audit, education and research purposes. This interaction is essential to optimise 
improving patient outcomes and ensure high quality care for patients with rectal cancer.
Total mesorectal excision (TME) has become the surgical treatment of choice in operable rectal cancer[1], 
and high quality TME is vital in reducing the risk of local recurrence. If a patient with a low rectal cancer 
requires an abdominoperineal excision (APE), the mesorectum should be removed intact as for a TME 
but also careful thought should be given to the plane of dissection around the sphincters/levators. The 
quality of surgery can be determined by pathological assessment of the plane of dissection compared to 
the intended planes, with a focus on the mesorectal plane in all major resectional specimens[2] and an 
additional assessment of the sphincter plane in APE[3]. In addition, involvement of the circumferential 
resection margin (CRM) can be used as a marker of the quality of surgery, although this is partly 
inf luenced by tumour extent[4]. Optimal surgery should aim for an intact specimen in the planned 
dissection plane with an uninvolved CRM.
Magnetic resonance imaging (MRI) is routinely used to stage rectal tumours preoperatively, to plan the 
optimal dissection plane and to re-assess tumours following neoadjuvant therapy. Pathologists provide 
feedback and quality control to radiologists on their accuracy of staging, prediction of CRM involvement, and 
response to neoadjuvant treatment. Oncologists can also benefit from feedback on response to neoadjuvant 
treatment, which gives important prognostic information and can be used to tailor further treatment.
Pathologists dissecting and analysing rectal cancer specimens must produce an accurate report not only 
containing all important staging and prognostic information, but also allowing the evaluation of the quality 
of other clinical services, notably radiology, surgery and oncology. For this reason, we advocate the use of a 
structured proforma for reporting, e.g., the Royal College of Pathologists dataset for colorectal cancer[5].
This review will focus on how pathological assessment can be used to evaluate and optimise the quality of 
rectal cancer treatment as well as the evidence underpinning this.
SURGICAL ANATOMY OF TME/ANTERIOR RESECTION SPECIMENS
Above the anal sphincter complex, the muscularis propria of the rectum is surrounded by a variable 
layer of perirectal mesenteric fat known as the mesorectum, which is in direct continuity with the 
mesocolon. The mesorectum is of upmost importance in rectal cancer surgery as it contains all the 
structures, including blood vessels, nerves, lymphatic drainage, and lymph nodes, by which rectal cancers 
can potentially disseminate. A layer of visceral fascia completely surrounds the mesorectum below the 
peritoneal ref lections, with this mesorectal fascia continuing posteriorly to the apex of the mesorectal 
triangle. Above the peritoneal reflections, the anterior and lateral mesorectum is covered by peritoneum 
[Figure 1]. The mesorectal fascia and peritoneum together create the external surface of a surgical “package”, 
which should be removed intact with optimal TME surgery.
The volume of the mesorectum varies significantly between individuals and in different regions of 
the structure, with the greatest volume seen posteriorly and a thinner layer anteriorly[6]. It is therefore 
unsurprising that involvement of the CRM and intra-operative perforations are more commonly seen at 
the anterior aspect of the specimen[6,7]. The greatest volume of mesorectum is found in the mid rectum, 
distal to which the structure gradually narrows to a point of maximum wasting at the level of puborectalis, 
approximately 4 cm above the anal verge[8].
During TME surgery, the aim is to perform precise dissection within the mesorectal fascial plane to create 
an intact surgical “package” containing the primary tumour and surrounding mesorectum[1]. The non-
peritonealised surface of the specimen forms the surgically created CRM, although this margin is only 
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Figure 1. Anterior resection specimen for rectal cancer demonstrating the peritoneal reflection (marked in blue solid line) at the anterior 
aspect (A) and the mesorectal apex (marked in blue dotted line) at the posterior aspect (B). CRM: circumferential resection margin
truly circumferential below the level of the anterior peritoneal reflection. The CRM should be covered by 
mesorectal fascia if surgery has been carried out in the optimal mesorectal plane[1].
Involvement of the CRM by tumour, defined as tumour 1 mm or less from the margin, is strongly 
associated with local recurrence and is an adverse prognostic feature[4,9]. This involvement can occur 
through direct extension of the main tumour; by tumour in nerves, blood vessels, lymphatic channels 
or lymph nodes; or discontinuous tumour deposits[5]. Advances in MRI mean that radiologists can make 
excellent predictions for CRM involvement and play a vital role in selecting patients who may benefit from 
preoperative therapy[10].
There are two main causes of the primary tumour involving the CRM. Either the tumour is advanced and 
involving the mesorectal fascia, or the tumour is clear of the fascia but the surgeon has failed to stay in 
the correct dissection plane. Advanced tumours extending to within 1 mm of the mesorectal fascia should 
be identified in advance by MRI and may benefit from more extensive surgery or preoperative treatment 
to shrink the tumour to a surgically resectable state. If the CRM is involved by primary tumour with the 
specimen in the mesorectal plane, either the involved CRM should have been expected or the radiologist 
has failed to identify the advanced nature of the disease.
The introduction of TME and surgical training initiatives have led to a significant reduction in the rate 
of local recurrence and improved survival in both large-scale population series and clinical trials[11-13]. A 
major contributing factor to this improvement is thought to be the reduction in CRM involvement and 
suboptimal planes of surgery associated with TME[4].
SURGICAL ANATOMY OF APE SPECIMENS
APE of the rectum and anus is frequently utilised as the surgical treatment of choice in patients with 
advanced low rectal tumours (within 6 cm of the anal verge), although the operation may be used for higher 
tumours if poor function is predicted. The “conventional” APE involves an abdominal and a perineal phase; 
the abdominal phase is essentially a TME, and this is followed by the perineal phase, traditionally with the 
patient in the lithotomy position, that involves dissection outside the anal sphincters to meet the TME plane.
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Approximately 25% of patients with rectal cancer undergo APE surgery, although there is considerable 
variation in APE rates between hospitals[14,15]. There have been concerns raised that APE surgery is 
overused in some centres and it has been proposed that the rate of APE surgery may be used as a surrogate 
marker for surgical quality[16,17]. The outcome after APE surgery for low rectal cancer in several studies is 
poorer in terms of patient outcome when compared to anterior resections for higher rectal tumours[6,18]. As 
previously described, the mesorectum narrows to a waist at the level of puborectalis and commencement 
of the sphincters, therefore unlike mid or high rectal tumours, there is less protective tissue between the 
tumour and the CRM in low rectal tumours when following the “conventional” TME plane. In addition, 
visualisation in a “conventional” APE may be poor in the lithotomy position during perineal dissection 
and may lead to surgeons deviating into the wrong tissue plane. These factors are likely to account for the 
increased CRM involvement rate in APE surgery[6,7] and increased risk of intraoperative perforations[19,20]. 
In cases of advanced anterior tumours, an en bloc prostatectomy or resection of the posterior vaginal wall 
may be carried out due to the negligible perirectal tissue present anteriorly, in order to increase the chances 
of an R0 resection[6].
Development of more radical techniques for advanced tumours, e.g., extralevator APE has led to improved 
clinical outcomes in some studies through a reduction in CRM involvement and perforations compared 
to “conventional” APE surgery[7,21,22]. Extralevator APE involves the removal of the levator ani with the 
mesorectum and anal sphincters, creating a more cylindrically shaped specimen and thereby providing 
critical extra tissue around a low rectal tumour[22]. Surgical variations in this technique, including use of 
the prone jack-knife position, mean that visualisation of the perineal dissection is also improved, helping to 
reduce the risk of straying into the wrong tissue plane[22]. A multicentre European study comparing a large 
series of extralevator APE to “conventional” APE found that extralevator APE removed significantly more 
tissue around low rectal cancers with a reduction in CRM involvement (50% to 20%, P < 0.001) and reduction 
in intraoperative perforations (28% to 8%, P < 0.001)[23]. Similarly, a 2011 systematic review found a reduction 
when comparing extralevator APE to conventional APE in CRM involvement (9.6% vs. 15.4%, P = 0.022), 
bowel perforation (4.1% vs. 10.4%, P = 0.004), and local recurrence rate (6.6% vs. 11.9%, P < 0.001)[24].
THE ROLE OF PHOTOGRAPHY IN SPECIMEN QUALITY CONTROL
A key component in facilitating feedback on the quality of surgical specimens is keeping a permanent 
record of each specimen using digital photography. Digital images should be taken of the anterior and 
posterior aspect of the whole intact specimen, preferably prior to inking, opening and fixation, alongside 
a metric scale for calibration. Any significant defects in the mesorectal fascia, sphincters or perforations 
warrant a close-up image. Similarly, digital images should be routinely taken of the serial cross-sectional 
slices taken at 3-5 mm intervals through the tumour to confirm the plane of surgery and demonstrate the 
relationship of the tumour to the CRM. In APE, additional close-up images should be taken of the front 
and back of the anal canal/sphincter/levator area to record the plane of surgery in this area. Lateral images 
may also be helpful. These images should be stored in a departmental archive and should be actively used 
in MDT meetings to feed back to surgical colleagues and compare to the radiological appearances. In 
addition they can be used for education, research and audit purposes.
PATHOLOGICAL ASSESSMENT OF ANTERIOR RESECTION SPECIMENS
The anatomy of the specimen depends on several factors including the positioning of the tumour, 
the quality of surgical dissection, whether a partial or total mesorectal excision has been performed, 
whether additional structures have been removed and the individual variation in height of the peritoneal 
ref lections. The first step is to grade the quality of the mesorectum. The recommended three-point 
grading system for assessment of mesorectal dissection can be seen in Table 1[25] and macroscopic images 
demonstrating these planes of dissection can be found in the Royal College of Pathologists dataset for 
colorectal cancer[5]. Examples of mesorectal and intramesorectal plane surgery can be seen in Figure 2. 
Grading of the mesorectal plane of excision is a key marker for surgical quality and plays a vital role in 
providing continual feedback to the MDT team for educational and audit purposes. Feeding back the 
planes of mesorectal surgery in the MRC CR07 trial led to a gradual improvement in specimen quality over 
the duration of the trial[26].
Prior to dissecting the specimen, the external surface should be carefully examined by a histopathologist 
to ensure all key prognostic features are identified and described. We recommend the description and 
dissection method developed in Leeds and adopted by the Royal College of Pathologists for use in 
colorectal cancer reporting to ensure consistent and thorough assessment[5,27]. It is essential that the 
specimen is received intact, and preferably fresh, to allow accurate assessment of both the mesorectal plane 
and the CRM, as well as taking the whole specimen photographs. The mesorectal fascia may be easier to 
identify and assess in fresh tissue as it will appear as a shiny smooth layer, whereas following formalin 
fixation the fascia can become distorted and appear dull and opaque.
Any disruptions in the mesorectal fascia should be described in terms of their depth and extent, and the 
presence of surgical perforation, a communication between the surface of the specimen and the lumen of 
the bowel, should also be documented in the pathology report [Figure 3]. Tumour perforations above the 
peritoneal reflections are associated with an increased risk of intraperitoneal recurrence and have a poor 
prognosis[28]; these are classified as pT4a using TNM8 staging[29]. Perforations through the CRM commonly 
occur in addition to perforations through the peritoneum, especially in APE specimens, and usually involve 
the anterior aspect, where the mesorectum is at its thinnest[19]. Although technically not classified as pT4a 
under TNM rules, these are also associated with a high risk of local recurrence[20] and reduced survival[30].
PATHOLOGICAL ASSESSMENT OF APE SPECIMENS
APE specimens should be received intact, ideally fresh and should be assessed by pathologists in a very 
similar way to that for anterior resection specimens as described above. Specifically, the mesorectal plane of 
excision and presence of intraoperative perforations should be evaluated and specimen photographs should 
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Table 1. Three-point grading system for the assessment of the plane of mesorectal dissection in total mesorectal excision/
anterior resection specimens for rectal cancer
CRM: circumferential resection margin
Grade of excision Quality of surgery Description
Mesorectal Good surgery Intact smooth mesorectal surface with only minor irregularities. Any defects must be no 
deeper than 5 mm. No coning of the specimen distally. Smooth CRM on slicing
Intramesorectal Moderate surgery Moderate bulk to mesorectum but irregularity of the mesorectal surface. Moderate distal 
coning. Muscularis propria not visible with the exception of levator insertion. Moderate 
irregularity of CRM on slicing
Muscularis propria Poor surgery Little bulk to mesorectum with defects down onto the muscularis propria and/or very 
irregular CRM. It includes perforations through the CRM
Figure 2. Cross sectional slices showing a mesorectal plane specimen with smooth circumferential resection margin (CRM) (left) and 
intramesorectal plane specimen with irregularity to the CRM and obvious defects, but no evidence of defects extending to the muscle 
tube (right)
be taken. An additional assessment of the surgical plane of dissection around the levator/sphincter area is 
an important indicator of APE quality and needs to be assessed carefully by the pathologist; macroscopic 
images demonstrating the three surgical planes of dissection can be found in the Royal College of 
Pathologists dataset for colorectal cancer[5]. A study by Martijnse et al.[31] is an example of how an increased 
focus on the quality of perineal dissection in APE surgery can lead to improved quality of surgery and a 
significant reduction in the number of involved resection margins [Figure 4]. The recommended three-
point grading system can be seen in Table 2[3].
PATHOLOGICAL ASSESSMENT OF THE CRM
Involvement of the CRM is a key prognostic marker in rectal cancer and therefore care needs to be taken to 
ensure accurate histopathological assessment. The importance of an involved CRM increases after preoperative 
treatment as it is associated with increased risk of local failure, local recurrence and poor survival[9,18].
Following macroscopic assessment of the mesorectal plane (and sphincter planes in APE), whole specimen 
photography and after a period of formalin fixation (at least 48 hours to facilitate thin cross sectional 
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Figure 3. Anterior resection specimen showing a large anterior perforation with a defect into the lumen of the bowel (left), which is 
confirmed on cross sectional slicing where part of the anterior rectal wall is missing (right)
Figure 4. Two abdominoperineal specimens, the first resected in the sphincteric plane with an obvious area of waisting towards the base 
of the mesorectum/top of the sphincters (left) and the second resected in the extra-levator plane with no visible waisting (right)
slices), the CRM of the specimen should be inked, e.g., with India ink to allow histological identification 
of the margin and accurate measurement. It is important that the peritoneal surface is not inked as 
involvement of the peritoneum is a risk factor for peritoneal recurrence rather than the local recurrence 
seen following CRM involvement.
The specimen should then be sliced transversely at 3-5 mm intervals and the slices laid out sequentially to 
visualise the relationship between the tumour and the CRM. A minimum of five tumour blocks should 
be processed for histological examination and at least one should include the closest tumour to the inked 
CRM[5]. Tumour can involve the CRM through primary extension, discontinuous spread/tumour deposits, 
lymph node metastases (with and without extracapsular spread) and along nerves, veins and lymphatics 
[Figure 5]. Any lymph nodes or suspicious vascular structures close to the CRM should therefore be 
embedded with the inked margin intact. It is mandatory that the pathology report includes a comment 
regarding tumour involvement of the CRM, as if appropriate the patient may be offered adjuvant therapy 
to reduce the subsequent risk of local recurrence[5,32]. The nearest distance of the tumour to the CRM 
should also be recorded and if involved the mechanism and extent of involvement may be helpful. It should 
be noted that the relative importance of lymph node metastases at the CRM is relatively underreported, 
however, limited evidence suggests that this may have less impact than other mechanisms of involvement[4]. 
Biologically one would expect that tumour in a lymph node with an intact lymph node capsule and intact 
mesorectal fascia is likely to have a lower risk of local recurrence when compared to extracapsular lymph 
node spread with mesorectal defects.
The status of the CRM and mechanisms of involvement should be specifically fed back to the radiologists 
at the MDT meeting to enable them to audit their preoperative predictions for CRM involvement. 
Radiological assessment following neoadjuvant therapy is of increasing importance; MRI prediction 
of involvement of the CRM following preoperative treatment is associated with a greater risk of local 
recurrence[33]. Feedback from the pathologist as to whether any fibrosis extends towards the CRM is 
very helpful to enable correlation with MRI findings. In cases where there is a discrepancy between the 
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Figure 5. Cross sectional slices from two specimens showing involvement of the circumferential resection margin (CRM) by primary 
tumour. The first has macroscopically visible tumour extending to the margin and was correctly identified as CRM involved on MRI (left); 
the second has extensive fibrosis following pre-operative chemoradiotherapy and the post treatment MRI predicted a clear margin, but 
small microscopic islands of residual viable tumour were present at the CRM (right)
Table 2. Three-point grading system for the assessment of the plane of anal canal/sphincter dissection in abdominoperineal 
excision specimens for low-rectal cancer
CRM: circumferential resection margin
Grade Description
Extra-levator plane The specimen has a cylindrical shape due to the presence of levator ani removed en bloc  with the mesorectum and 
sphincters. Any defects must be no deeper than 5 mm. No waisting of the specimen. Smooth CRM on slicing
Sphincteric plane The specimen is waisted and the CRM in this region is formed by the surface of the sphincter muscles which have 
been removed intact
Intrasphincteric plane The specimen is waisted and includes deviations into the sphincter muscles, submucosa and complete perforations
radiological prediction and the final pathology, effort should be made by the pathologist to indicate why 
this is the case. One important factor may be correlation with the plane of surgery, i.e., an involved margin 
being caused by failure to resect in the planned dissection plane. Another common cause of discrepancy is 
the identification of CRM involvement through microscopic nodal deposits and small vessel invasion that 
could not be visualised radiologically.
Feedback on the degree of response to neoadjuvant treatment is also very helpful for the oncologists in 
terms of regression away from the CRM and general tumour regression grading in order to understand the 
sensitivity of individual tumours to specific treatments and to plan subsequent treatment. The four point 
tumour regression grading system from TNM8 should be used in all pathology reports; this can be found 
in the latest Royal College of Pathologists dataset for colorectal cancer[5,29].
THE ROLE OF MDT EDUCATION IN IMPROVING THE QUALITY OF TREATMENT FOR RECTAL 
CANCER
The MDT provides a patient-centred forum and an opportunity to optimise the treatment plan, improve 
quality of care for patients with cancer, and is likely linked to improved rates of curative resection[34]. 
Education of the MDT gives a unique opportunity to optimise surgical practice, improve decision 
making for preoperative treatment, and advance the overall quality of care for patients[35]. Education 
programmes directed primarily at surgeons have been shown to improve the oncological quality of surgical 
specimens and patient outcomes in Netherlands, Norway and Sweden[13]. The National Pelican MDT 
TME Development Programme was an educational programme aimed at the whole CRC MDT and was 
delivered through the Pelican Cancer Foundation in England[36]. Although there is limited evidence for the 
direct effect of the programme, outcomes for rectal cancer patients in the UK were significantly improved 
over this time period and a further government funded National MDT educational programme focusing 
on low rectal cancer called the Low Rectal Cancer Development Programme (LOREC) was launched 
a few years later[37]. The aim of LOREC was to improve the poor outcomes associated with low rectal 
cancer by focusing on preoperative imaging, selective neoadjuvant therapy, optimal surgical treatment, 
specialist nursing, and detailed histopathological assessment. LOREC ran workshops for all colorectal 
MDT members and take-up across England was excellent with approximately 90% of MDTs attending and 
a total 1019 participants[3 7]. These received excellent feedback and 96% of surgeons attending said it would 
alter their future practice[37,38]; local audit has also shown a change in surgical practice associated with good 
outcomes following the workshops[39]. LOREC has shown the potential positive impact that education on 
MDTs can have. A further programme focusing on early colorectal cancers, the Significant Polyp & Early 
Colorectal Cancer, has recently finished and there is an ongoing programme, Improving Management for 
Patients with Advanced Colorectal Tumour, with a focus on advanced and metastatic cancers[40].
CONCLUSION
Outcomes for patients with rectal cancer have markedly improved over the last two decades; these 
improvements have resulted from a number of interventions including the description and widespread 
introduction of TME surgery[1,41], the use of MRI for preoperative staging[42,43], and the use of neoadjuvant 
treatment[44,45]. Histopathologists who dissect and report rectal cancer specimens have played an essential 
role in improving patient outcomes by recognising the importance of the CRM[9], as well as describing the 
assessment of surgical planes of dissection as a means of quality control[26]. More recent focus has been 
on the poor outcomes associated with traditional APE surgery for low rectal cancer and pathologists have 
played a vital role in this, by identifying evidence to support changes in practice for surgeons, radiologists, 
oncologists and pathologists. Many of these improvements have been supported by national MDT 
education/development programmes leading to a rapid uptake in optimal practice.
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In summary, pathologists are able to assess the quality of surgery of anterior resections by assessing the 
plane of mesorectal excision, involvement of the CRM and presence of intraoperative perforations. In APE 
specimens, the same quality markers are used with the addition of an assessment of the plane of sphincter/
levator dissection as a surrogate marker for surgical quality in the critical area commonly associated with 
CRM involvement/perforations. Feedback on the planes of surgery, as well as other important prognostic 
information, is essential to the MDT and can benefit not only surgeons, but oncologists and radiologists. 
Pathologists must provide detailed, accurate reports encompassing all important prognostic markers as 
well as an evaluation of surgical quality. Consistent feedback to the colorectal MDT is essential to further 
improve outcomes for patients with rectal cancer.
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